S05520 Summary:

BILL NOS05520B
 
SAME ASNo same as
 
SPONSORGIPSON
 
COSPNSRCARLUCCI, HOYLMAN, LATIMER, PARKER, PERKINS, SAVINO
 
MLTSPNSR
 
Add S230-e, Pub Health L
 
Authorizes long term antibiotic treatment for certain patients with Lyme disease and provides that physicians shall not be subject to disciplinary action for such treatment.
Go to top    

S05520 Actions:

BILL NOS05520B
 
05/16/2013REFERRED TO HEALTH
05/28/2013AMEND AND RECOMMIT TO HEALTH
05/28/2013PRINT NUMBER 5520A
01/08/2014REFERRED TO HEALTH
04/30/2014AMEND AND RECOMMIT TO HEALTH
04/30/2014PRINT NUMBER 5520B
Go to top

S05520 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S05520 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5520--B
 
                               2013-2014 Regular Sessions
 
                    IN SENATE
 
                                      May 16, 2013
                                       ___________
 
        Introduced by Sens. GIPSON, CARLUCCI, HOYLMAN, LATIMER -- read twice and
          ordered  printed, and when printed to be committed to the Committee on
          Health -- committee discharged, bill  amended,  ordered  reprinted  as
          amended  and  recommitted  to  said  committee  --  recommitted to the
          Committee on Health in accordance  with  Senate  Rule  6,  sec.  8  --

          committee  discharged,  bill amended, ordered reprinted as amended and
          recommitted to said committee
 
        AN ACT to amend the public health law, in relation to  authorizing  long
          term antibiotic treatment for certain patients with Lyme disease
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1.  Legislative  findings  and  intent.  Lyme  disease  is  an
     2  infection transmitted to humans by ticks at epidemic proportions.  Based
     3  on  New York state department of health figures, over 50,000 state resi-
     4  dents contracted Lyme disease in 2012  alone.    In  the  case  of  Lyme
     5  disease,  the  practice  of  medicine  has  not  kept pace with research
     6  advances on the biological agents responsible for the disease  symptoms.
     7  Outdated  and  disputed diagnostic and treatment guidelines prevent many

     8  of those afflicted from receiving evidenced-based treatment options that
     9  could mean the difference between a healthy life and one of chronic pain
    10  and progressive disability. Where science  and  medicine  are  evolving,
    11  patients'  rights  must  be paramount. Patients with Lyme disease should
    12  have the same rights as those with other diseases. They  must  have  the
    13  right  to  be seen and treated by the practitioner of their choice, have
    14  the right to be informed that there are differing professional judgments
    15  about appropriate care for Lyme  disease,  and  to  participate  in  the
    16  choice of treatment as it pertains to their circumstance and preference.
    17  The rights of the patients hinge upon the ability of the practitioner to
    18  act  in  the  best interest of the patient without fear of reprisal from
    19  the professional discipline system when more than one set of  guidelines
 

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11023-09-4

        S. 5520--B                          2
 
     1  exist.  This  legislation  intends  to protect the rights of patients to
     2  access evidence-based treatment options for Lyme disease, in New York.
     3    § 2. The public health law is amended by adding a new section 230-e to
     4  read as follows:
     5    §  230-e. Diagnosis and treatment of Lyme disease. 1. For the purposes
     6  of this section, the following terms shall have the following meanings:
     7    (a) "Lyme disease" means the professional clinical  diagnosis  of  the
     8  presence  in  a  patient  of  signs  and  symptoms compatible with acute

     9  infection with Borrelia burgdorferi,  or  with  late  stage  or  chronic
    10  infection  with  Borrelia  burgdorferi, or with complications related to
    11  such an infection. "Lyme disease" includes  infection  which  meets  the
    12  surveillance  criteria  set  forth by the US Centers for Disease Control
    13  and Prevention (CDC), but also includes other acute and chronic manifes-
    14  tations of such an infection as determined by a diagnosing  health  care
    15  professional.
    16    (b)  "Long  term  antibiotic  therapy"  means  administration of oral,
    17  intramuscular or intravenous antibiotics, singly or in combination,  for
    18  periods of greater than four weeks.
    19    (c)  "Health  care  professional"  means  a  health  care professional

    20  authorized to practice under title eight of the  education  law,  acting
    21  within the lawful scope of his or her practice.
    22    2.  A  health care professional may prescribe, administer, or dispense
    23  antibiotic therapy to a patient in order to eliminate such infection  or
    24  control  a  patient's  symptoms upon making a clinical diagnosis of Lyme
    25  disease. No health care professional shall be  subject  to  professional
    26  discipline  under  this  article or title eight of the education law for
    27  prescribing, administering or dispensing long-term antibiotic therapy or
    28  other care that the health care professional determines to be reasonable
    29  and intended  to  benefit  a  patient  clinically  diagnosed  with  Lyme
    30  disease.

    31    §  3.  This  act  shall take effect immediately and shall apply to any
    32  professional discipline matter  or  administrative  or  judicial  review
    33  thereof pending on or after the date on which this act takes effect.
Go to top